Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 583931, 8 pages
http://dx.doi.org/10.1155/2015/583931
Research Article

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: MRI and 18F-FDG PET Quantitative Analysis Using FreeSurfer

1Service de Médecine Nucléaire, CHRU de Tours, boulevard Tonnellé, 37000 Tours, France
2Service de Médecine Nucléaire, CHR Orléans, avenue de l’Hôpital, 45000 Orléans, France
3INSERM U930, Université François Rabelais, boulevard Tonnellé, 37000 Tours, France
4Consultation Mémoire, CHRU de Tours, boulevard Tonnellé, 37000 Tours, France
5Service de Neuroradiologie, CHRU de Tours, boulevard Tonnellé, 37000 Tours, France
6INSERM CIC 1415, boulevard Tonnellé, 37000 Tours, France
7CEA/DSV/I2BM/CI-NAPS UMR6232, 14000 Caen, France
8INSERM U825, Université Paul Sabatier, 31400 Toulouse, France

Received 21 December 2014; Accepted 24 May 2015

Academic Editor: Adriana Alexandre Tavares

Copyright © 2015 Matthieu Bailly et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Dubois, H. H. Feldman, C. Jacova et al., “Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria,” The Lancet Neurology, vol. 6, no. 8, pp. 734–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. McKhann, D. S. Knopman, H. Chertkow et al., “The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease,” Alzheimer's and Dementia, vol. 7, no. 3, pp. 263–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Dubois, H. H. Feldman, C. Jacova et al., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria,” The Lancet Neurology, vol. 13, no. 6, pp. 614–629, 2014. View at Publisher · View at Google Scholar
  4. B. Dubois, H. H. Feldman, C. Jacova et al., “Revising the definition of Alzheimer's disease: a new lexicon,” The Lancet Neurology, vol. 9, no. 11, pp. 1118–1127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Scheltens, D. Leys, F. Barkhof et al., “Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 10, pp. 967–972, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Chételat, “La neuro-imagerie au service de la maladie d'Alzheimer,” Médecine Sciences, vol. 27, no. 2, pp. 193–198, 2011. View at Publisher · View at Google Scholar
  8. B. Fischl, “FreeSurfer,” NeuroImage, vol. 62, no. 2, pp. 774–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Desikan, H. J. Cabral, B. Fischl et al., “Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease,” American Journal of Neuroradiology, vol. 30, no. 3, pp. 532–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Desikan, H. J. Cabral, C. P. Hess et al., “Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease,” Brain, vol. 132, no. 8, pp. 2048–2057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Su, G. M. D'Angelo, A. G. Vlassenko et al., “Quantitative analysis of PiB-PET with FreeSurfer ROIs,” PLoS ONE, vol. 8, no. 11, Article ID e73377, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Schain, K. Varnäs, Z. Cselényi, C. Halldin, L. Farde, and A. Varrone, “Evaluation of two automated methods for PET region of interest analysis,” Neuroinformatics, vol. 12, no. 4, pp. 551–562, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. Buckner, A. Z. Snyder, B. J. Shannon et al., “Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory,” The Journal of Neuroscience, vol. 25, no. 34, pp. 7709–7717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. G. McKhann, D. Drachman, and M. Folstein, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar
  16. R. C. Petersen, G. E. Smith, S. C. Waring et al., “Mild cognitive impairment: clinical characterization and outcome,” Archives of Neurology, vol. 56, no. 3, pp. 303–308, 1999. View at Publisher · View at Google Scholar
  17. E. Westman, L.-O. Wahlund, C. Foy et al., “Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimers Disease,” Journal of Alzheimer's Disease, vol. 26, supplement 3, pp. 307–319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Liu, T. Paajanen, Y. Zhang et al., “Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups—the AddNeuroMed study,” Neurobiology of Aging, vol. 32, no. 7, pp. 1198–1206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Liu, T. Paajanen, Y. Zhang et al., “Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease,” Neurobiology of Aging, vol. 31, no. 8, pp. 1375–1385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Liu, T. Paajanen, E. Westman et al., “Effect of APOE ε4 allele on cortical thicknesses and volumes: the addNeuroMed study,” Journal of Alzheimer's Disease, vol. 21, no. 3, pp. 947–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Liu, T. Paajanen, E. Westman et al., “APOE ε2 allele is associated with larger regional cortical thicknesses and volumes,” Dementia and Geriatric Cognitive Disorders, vol. 30, no. 3, pp. 229–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Thambisetty, A. Simmons, L. Velayudhan et al., “Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease,” Archives of General Psychiatry, vol. 67, no. 7, pp. 739–748, 2010. View at Publisher · View at Google Scholar
  23. E. Westman, C. Aguilar, J.-S. Muehlboeck, and A. Simmons, “Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment,” Brain Topography, vol. 26, no. 1, pp. 9–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. D. F. Benson, D. E. Kuhl, and R. A. Hawkins, “The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia,” Archives of Neurology, vol. 40, no. 12, pp. 711–714, 1983. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Minoshima, B. Giordani, S. Berent, K. A. Frey, N. L. Foster, and D. E. Kuhl, “Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease,” Annals of Neurology, vol. 42, no. 1, pp. 85–94, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. R Development Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2011.
  27. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society. Series B. Methodological, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar · View at MathSciNet
  28. Y. Cui, B. Liu, S. Luo et al., “Identification of conversion from mild cognitive impairment to alzheimer's disease using multivariate predictors,” PLoS ONE, vol. 6, no. 7, Article ID e21896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Lundqvist, J. Lilja, B. A. Thomas et al., “Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data,” The Journal of Nuclear Medicine, vol. 54, no. 8, pp. 1472–1478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. D. B. Chonde, N. Abolmaali, G. Arabasz, A. R. Guimaraes, and C. Catana, “Effect of MRI acoustic noise on cerebral fludeoxyglucose uptake in simultaneous MR-PET imaging,” Investigative Radiology, vol. 48, no. 5, pp. 302–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. De Santi, M. J. De Leon, H. Rusinek et al., “Hippocampal formation glucose metabolism and volume losses in MCI and AD,” Neurobiology of Aging, vol. 22, no. 4, pp. 529–539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Chételat, B. Desgranges, B. Landeau et al., “Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease,” Brain, vol. 131, part 1, pp. 60–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. S. Karow, L. K. McEvoy, C. Fennema-Notestine et al., “Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early alzheimer disease,” Radiology, vol. 256, no. 3, pp. 932–942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Yang, P. Pan, W. Song et al., “Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation,” Journal of the Neurological Sciences, vol. 316, no. 1-2, pp. 21–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Mosconi, “Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 4, pp. 486–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Fischl, D. H. Salat, E. Busa et al., “Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain,” Neuron, vol. 33, no. 3, pp. 341–355, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Fischl, A. van der Kouwe, C. Destrieux et al., “Automatically parcellating the human cerebral cortex,” Cerebral Cortex, vol. 14, no. 1, pp. 11–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Klein, J. Andersson, B. A. Ardekani et al., “Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration,” NeuroImage, vol. 46, no. 3, pp. 786–802, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. H. B. M. Gronenschild, P. Habets, H. I. L. Jacobs et al., “The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements,” PLoS ONE, vol. 7, no. 6, Article ID e38234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Minoshima, K. A. Frey, N. L. Foster, and D. E. Kuhl, “Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis,” Journal of Computer Assisted Tomography, vol. 19, no. 4, pp. 541–547, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Dukart, K. Mueller, A. Horstmann et al., “Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies,” NeuroImage, vol. 49, no. 2, pp. 1490–1495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Küntzelmann, T. Guenther, U. Haberkorn et al., “Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization,” Neuroscience Letters, vol. 534, no. 1, pp. 12–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. K. B. Walhovd, L. T. Westlye, I. Amlien et al., “Consistent neuroanatomical age-related volume differences across multiple samples,” Neurobiology of Aging, vol. 32, no. 5, pp. 916–932, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Barnes, G. R. Ridgway, J. Bartlett et al., “Head size, age and gender adjustment in MRI studies: a necessary nuisance?” NeuroImage, vol. 53, no. 4, pp. 1244–1255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. T. Farias, D. Mungas, B. Reed et al., “Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology,” Neurobiology of Aging, vol. 33, no. 8, pp. 1758–1768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Chow, K. S. Hwang, S. Hurtz et al., “Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's disease neuroimaging initiative,” American Journal of Neuroradiology, vol. 36, no. 4, pp. 653–660, 2015. View at Publisher · View at Google Scholar
  47. C. M. Clark, J. A. Schneider, B. J. Bedell et al., “Use of florbetapir-PET for imaging beta-amyloid pathology,” The Journal of the American Medical Association, vol. 305, no. 3, pp. 275–283, 2011. View at Publisher · View at Google Scholar